Anastomotic Leak, Gastric Cancer
Conditions
Keywords
Gastric Cancer, Anastomotic leakage, Human albumin
Brief summary
We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.
Detailed description
Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical postoperative complication. Anastomotic leakage severely compromises the recovery after surgery. It increases the overall burden of patients and hospital resources. Postoperative mortality is higher in patients with anastomotic leakage. Human albumin is routinely administered after surgery with a unproven hypothesis that the human albumin is beneficial to prevent anastomotic leakage. We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.
Interventions
BIOLOGICALHuman albumin
Patients received intravenous human albumin after gastric cancer surgery. Overall quantity of human albumin were recorded.
Sponsors
Ruijin Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Histologically confirmed gastric cancer * Patients who underwent radical gastrectomy
Exclusion criteria
* Patient who did not undergo gastrectomy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of the rate of anastomotic leakage | Up to one months after the discharge of last patient | The rate of anastomotic leakage were compared among both groups |
Outcome results
None listed